The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood
Open accessAbstract
Enrichment of rare circulating tumor cells (CTCs) in blood is typically achieved using antibodies to epithelial cell adhesion molecule (EpCAM), with detection using cytokeratin (CK) antibodies. However, EpCAM and CK are not expressed in some tumors and can be downregulated during epithelial-to-mesenchymal transition. A micro-fluidic system, not limited to EpCAM or CK, was developed to use multiple antibodies for capture followed by detection using CEE-Enhanced (CE), a novel in situ staining method that fluorescently labels the capture antibodies bound to CTCs. Higher recovery of CTCs was demonstrated using antibody mixtures compared to anti-EpCAM. In addition, CK-positive breast cancer cells were found in 15 of 24 samples (63%; range 1–60 CTCs), while all samples contained additional CE-positive cells (range 1–41; median = 11; ). Thus, antibody mixtures against a range of cell surface antigens enables capture of more CTCs than anti-EpCAM alone and CE staining enables the detection of CK-negative CTCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Nagrath, S., Sequist, L. V., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., Smith, M. R., Kwak, E. L., Digumarthy, S., Muzikansky, A., et al. (2007) · Nature · doi:10.1038/nature06385 · Cited by 3,559
Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0378 · Cited by 2,542 · cited 2×
“The FDA-approved CellSearch system has set the standard for the use of EpCAM in the enrichment of CTCs using a magnetic ferrofluid approach [3, 4].”
BackgroundMethodde Bono, J. S., Scher, H. I., Montgomery, R. B., Parker, C., Miller, M. C., Tissing, H., Doyle, G. V., Terstappen, L. W. W. M., Pienta, K. J., & Raghavan, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0872 · Cited by 2,182
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
Stott, S. L., Hsu, C.-H., Tsukrov, D. I., Yu, M., Miyamoto, D. T., Waltman, B. A., Rothenberg, S. M., Shah, A. M., Smas, M. E., Korir, G. K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012539107 · Cited by 1,634
The human keratins: biology and pathology
Moll, R., Divo, M., & Langbein, L. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0435-6 · Cited by 1,465
Riethdorf, S., Fritsche, H., Müller, V., Rau, T., Schindlbeck, C., Rack, B., Janni, W., Coith, C., Beck, K., Jänicke, F., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1695 · Cited by 1,338
Circulating Tumor Cells in Patients with Breast Cancer Dormancy
Meng, S., Tripathy, D., Frenkel, E. P., Shete, S., Naftalis, E. Z., Huth, J. F., Beitsch, P. D., Leitch, M., Hoover, S., Euhus, D., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1110 · Cited by 971
Circulating tumor cells (CTC) detection: Clinical impact and future directions
Paterlini-Brechot, P., & Benali, N. L. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.014 · Cited by 947
Frequent EpCam protein expression in human carcinomas
Went, P. T. H., Lugli, A., Meier, S., Bundi, M., Mirlacher, M., Sauter, G., & Dirnhofer, S. (2004) · Human Pathology · doi:10.1016/j.humpath.2003.08.026 · Cited by 819
Scher, H. I., Jia, X., de Bono, J. S., Fleisher, M., Pienta, K. J., Raghavan, D., & Heller, G. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70340-1 · Cited by 611
Attard, G., Swennenhuis, J. F., Olmos, D., Reid, A. H. M., Vickers, E., A'Hern, R., Levink, R., Coumans, F., Moreira, J., Riisnaes, R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3667 · Cited by 533
Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer
Shaffer, D. R., Leversha, M. A., Danila, D. C., Lin, O., Gonzalez-Espinoza, R., Gu, B., Anand, A., Smith, K., Maslak, P., Doyle, G. V., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2701 · Cited by 338
Hofman, V., Bonnetaud, C., Ilie, M. I., Vielh, P., Vignaud, J. M., Fléjou, J. F., Lantuejoul, S., Piaton, E., Mourad, N., Butori, C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0445 · Cited by 308
High Ep-CAM Expression is Associated with Poor Prognosis in Node-positive Breast Cancer
Spizzo, G., Gastl, G., Obrist, P., Went, P., Dirnhofer, S., Bischoff, S., Mirlacher, M., Sauter, G., Simon, R., Stopatschinskaya, S., et al. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000036787.59816.01 · Cited by 254
Fehm, T., Hoffmann, O., Aktas, B., Becker, S., Solomayer, E. F., Wallwiener, D., Kimmig, R., & Kasimir-Bauer, S. (2009) · Breast Cancer Research · doi:10.1186/bcr2349 · Cited by 238
Coumans, F. A. W., Doggen, C. J. M., Attard, G., de Bono, J. S., & Terstappen, L. W. M. M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq030 · Cited by 210
Pestrin, M., Bessi, S., Galardi, F., Truglia, M., Biggeri, A., Biagioni, C., Cappadona, S., Biganzoli, L., Giannini, A., & Di Leo, A. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0461-7 · Cited by 201
Allan, A. L., & Keeney, M. (2010) · Journal of Oncology · doi:10.1155/2010/426218 · Cited by 196
Fehm, T., Becker, S., Duerr-Stoerzer, S., Sotlar, K., Mueller, V., Wallwiener, D., Lane, N., Solomayer, E., & Uhr, J. (2007) · Breast Cancer Research · doi:10.1186/bcr1783 · Cited by 196
Fluorescence In situ Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate Cancer
Leversha, M. A., Han, J., Asgari, Z., Danila, D. C., Lin, O., Gonzalez-Espinoza, R., Anand, A., Lilja, H., Heller, G., Fleisher, M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2036 · Cited by 188
Down-Regulated Expression of Cytokeratin 18 Promotes Progression of Human Breast Cancer
Wölfle, U., Sauter, G., Santjer, S., Brakenhoff, R. H., & Pantel, K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0114 · Cited by 146
Helo, P., Cronin, A. M., Danila, D. C., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.117952 · Cited by 138
Cytomorphology of Circulating Colorectal Tumor Cells: A Small Case Series
Marrinucci, D. C., Bethel, K. J., Lazar, D. C., Fisher, J., Huynh, E., Clark, P., Bruce, R., Nieva, J. J., & Kühn, P. (2010) · Journal of Oncology · doi:10.1155/2010/861341 · Cited by 126
Fehm, T. N., Solomayer, E., Meng, S., Tucker, T. F., Lane, N., Wang, J., & Gebauer, G. (2005) · Cytotherapy · doi:10.1080/14653240510027082 · Cited by 112
Camara, O., Kavallaris, A., Nöschel, H., Rengsberger, M., Jörke, C., & Pachmann, K. (2006) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-4-67 · Cited by 96
Tai, K.-Y., Shiah, S., Shieh, Y.-S., Kao, Y.-R., Chi, C.-Y., Huang, E., Lee, H.-S., Chang, L.-C., Yang, P.-C., & Wu, C.-W. (2007) · Oncogene · doi:10.1038/sj.onc.1210176 · Cited by 73
van der Gun, B. T. F., Wasserkort, R., Monami, A., Jeltsch, A., Raskó, T., Ślaska‐Kiss, K., Cortese, R., Rots, M. G., de Leij, L. F. M. H., Ruiters, M. H. J., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23476 · Cited by 24
Camara, O., Jörke, C., Hammer, U., Egbe, A., Rabenstein, C., Runnebaum, I. B., Hoeffken, K., & Pachmann, K. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0498-8 · Cited by 10
Cited by
Circulating tumor cell technologies
Ferreira, M. M., Ramani, V. C., & Jeffrey, S. S. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.01.007 · Cited by 511
Krebs, M. G., Hou, J.-M., Sloane, R., Lancashire, L., Priest, L., Nonaka, D., Ward, T. H., Backen, A., Clack, G., Hughes, A., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31823c5c16 · Cited by 463
Technologies for circulating tumor cell separation from whole blood
Bankó, P., Lee, S. Y., Nagygyörgy, V., Zrínyi, M., Chae, C. H., Cho, D. H., & Telekes, A. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0735-4 · Cited by 358
Ignatiadis, M., Lee, M., & Jeffrey, S. S. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1190 · Cited by 355
Circulating tumor cell isolation for cancer diagnosis and prognosis
Deng, Z., Wu, S., Wang, Y., & Shi, D. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.104237 · Cited by 284
Metadata
- Authors
- Mikolajczyk, S. D., Millar, L. S., Tsinberg, P., Coutts, S. M., Zomorrodi, M., Pham, T., Bischoff, F. Z., & Pircher, T. J.
- Venue
- Journal of Oncology
- Publisher
- Hindawi Limited
- Published
- 2011
- Volume
- 2011
- Pages
- 1-10
- ISSN
- 1687-8450 (ISSN-L)
- 1687-8469
- OpenAlex
- W2147244189
- Cited by
- 254
- References
- 28
- FWCI
- 11.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.